Advertisement

Autoradiographic Studies of 5HT2 Receptors

  • J. M. Saavedra
  • A. Himeno
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 294)

Abstract

Serotonin has been implicated in normal brain activities, and alterations in serotonin metabolism or serotonin receptors have been linked to disorders such as depression and schizophrenia (Fuller, 1986).

Keywords

Nucleus Accumbens Caudate Nucleus Human Platelet Total Binding Olfactory Tubercle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appel, J.B., and Freedman, D.X., 1968, Tolerance and cross-tolerance among psychotomimetic drugs, Psychopharmacologia, 13: 267–274.PubMedCrossRefGoogle Scholar
  2. Biegon, A., Weizman, A., Karp, L., Ram, A., Tiano, S., and Wolff, M., 1987, Serotonin 5-HT2 receptor binding on blood platelets — a peripheral marker for depression? Life Sci., 41: 2485–2492.PubMedCrossRefGoogle Scholar
  3. Bradford, M.M., 1976, A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding, Anal. Biochem., 72: 248–254.PubMedCrossRefGoogle Scholar
  4. Buckholtz, N.S., Freedman, D.X., and Middaugh, L.D., 1985, Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain, Eur. J. Pharmacol., 109: 421–425.PubMedCrossRefGoogle Scholar
  5. Carey, R.G., and Neal, T.L., 1986, The rat claustrum: afferent and efferent connections with visual cortex, Brain Res., 329: 185–193.CrossRefGoogle Scholar
  6. Fuller, R.W., 1986, Pharmacologic modification of serotonergic function: Drugs for the study and treatment of psychiatric and other disorders, J. Clin. Psych., 47: 4–8.Google Scholar
  7. Geaney, D.P., Schachter, M., Elliott, J.M., and Grahame-Smith, D.G., 1984, Characterization of [3H]-lysergic acid diethylamide binding to a 5-hydro-xytryptamine receptor on human platelet membranes, Eur. J. Pharmacol., 97: 87–93.PubMedCrossRefGoogle Scholar
  8. Glennon, R.A., McKenney, J.D., Lyon, R.A., and Titeler, M., 1986, 5HT1 and 5HT2 binding characteristics of l-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues, J. Med. Chem., 29: 194–199.PubMedCrossRefGoogle Scholar
  9. Glennon, R.A., Seggel, M.R., Soine, W.H., Herrick-Davis, K., Lyon, R.A., and Titeler, M., 1988, [125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5HT2 serotonin receptors, J. Med. Chem., 31: 5–7.PubMedCrossRefGoogle Scholar
  10. Israel, A., Correa, F.M.A., Niwa, M., and Saavedra, J.M., 1984, Quantitative determination of angiotensin II binding sites in rat brain and pituitary gland by autoradiography, Brain Res., 322: 341–345.PubMedCrossRefGoogle Scholar
  11. Jacobs, B.L., 1987, How hallucinogenic drugs work, Am. Sci., 75: 386–392.Google Scholar
  12. Johnson, M.P., Hoffman, A.J., Nichols, D.E., and Mathis, C.A., 1987, Binding to the serotonin 5HT2 receptor by the enantiomers of [125I]-DOI, Neuropharmacology, 26: 1803–1806.PubMedCrossRefGoogle Scholar
  13. Mann, J.J., Stanley, M., McBride, A., and McEwen, B., 1986, Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims, Arch. Gen. Psych., 43: 954–959.CrossRefGoogle Scholar
  14. McBride, P.A., Mann, J.J., Polley, M.J., Wiley, A.J., and Sweeney, J.A., 1987, Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets, Life Sci., 40: 1799–1809.PubMedCrossRefGoogle Scholar
  15. McKenna, D.J., Mathis, C.A., Shulgin, A.T., Sargent, T., 3rd, and Saavedra, J.M., 1987, Autoradiographic localization of binding sites for [125I]-DOI, a new psychotomimetic radioligand, in the rat brain, Eur. J. Pharmacol., 137: 289–290.PubMedCrossRefGoogle Scholar
  16. McKenna, D.J., Nazarali, A.J., Himeno, A., and Saavedra, J.M., 1989a, Chronic treatment with (±)DOI, a psychotomimetic 5-HT2 agonist, down-regulates 5-HT2 receptors in rat brain, Neuropsychopharmacology, 2: 81–87.PubMedCrossRefGoogle Scholar
  17. McKenna, D.J., Nazarali, A.J., Hoffman, A.J., Nichols, D.E., Mathis, C.A., and Saavedra, J.M., 1989b, Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]-LSD and [125I]-DOI, a new psychotomimetic radioligand, Brain Res., 476: 45–56.PubMedCrossRefGoogle Scholar
  18. McKenna, D.J.., and Saavedra, J.M., 1987, Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain, Eur. J. Pharmacol., 142: 313–315.PubMedCrossRefGoogle Scholar
  19. Miller, J.A., Curella, P., and Zahniser, N.R., 1988, A new densitometric procedure to measure protein levels in tissue slices used in quantitative autoradiography, Brain Res., 447: 60–66.PubMedCrossRefGoogle Scholar
  20. Nichols, D.E., Barfnecht, C.F., Rusterholz, D.B., Benington, F., and Morin, R.D., 1973, Asymmetric systhesis of psychotomimetic phenylisoproylamines, J. Med. Chem., 16: 480–483.PubMedCrossRefGoogle Scholar
  21. Pazos, A., Cortes, A., and Palacios, J.M., 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain, II. Serotonin-2 receptors, Brain Res., 346: 231–249.PubMedCrossRefGoogle Scholar
  22. Pierce, P.A., and Peroutka, S.J., 1988, Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide, J. Pharmacol. Exp. Ther., 247: 918–925.PubMedGoogle Scholar
  23. Scott, J.A., and Crews, F.T., 1986, Down-regulation of serotonin2 but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 or beta-adrenergic receptors, Neuropharmacology, 25: 1301–1306.PubMedCrossRefGoogle Scholar
  24. Shulgin, A.T., 1982, Chemistry of Psychotomimetics, in: “Handbook of Experimental Pharmacology”, Vol. 55, Part III, Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs, Hoffmeister, F., and Stille, G., eds., Springer-Verlag, Berlin, pp. 3–29.Google Scholar
  25. Wilhite, B.L., Teyler, T.J., and Hendricks, C., 1986, Functional relations of the rodent claustral-entorhinal-hippocampal system, Brain Res., 365: 54–60.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • J. M. Saavedra
    • 1
  • A. Himeno
    • 1
  1. 1.Section on Pharmacology Laboratory of Clinical ScienceNIMHBethesdaUSA

Personalised recommendations